Kratom Addiction Recovery Advocate Shares Warnings After Daily Use Spiraled

Kratom-related reports directed to U.S. poison centers climbed approximately 1,200% between 2015 and 2025, reaching a record high of 3,434 last year, according to data from the Centers for Disease Control and Prevention. Amid rising regulatory scrutiny and varying state laws, individuals who have struggled with dependence are speaking out about the risks associated with both natural leaf kratom and concentrated extracts.
Hilary Tesluck, a 30-year-old Michigan resident and executive director of the nonprofit End Kratom Addiction, began using kratom capsules in 2017 at age 21. Introduced by a friend seeking a holistic, natural alternative to prescription anxiety medication, Tesluck recalled that she did not recall any dosing instructions on the packaging. Initially, the substance provided an increase in energy, confidence, and productivity while she worked as an undergraduate student, tutor, and researcher.

Over time, however, her consumption escalated steadily. “Very slowly, over time, I had to take just one more capsule or just one more dose, and then went all the way up to 100,” Tesluck said. Her daily functioning deteriorated, leading to performance write-ups at work. Physically, she dropped nearly 40 pounds and experienced severe fatigue, noting she struggled even to stand in the shower because her body had wasted away. Feeling unable to reduce her intake without feeling sick, she found herself trapped by the substance.
Tesluck’s belief that kratom was natural and legal initially made her dependence difficult to accept. When she first sought treatment in 2020, she reported feeling dismissed because staff urine screenings did not detect the substance and personnel were unfamiliar with it, prompting her to leave after a few days and resume use. She found sustained help in 2021 through an online recovery meeting, describing the experience of hearing others share her story as a turning point. Although she experienced subsequent relapses—including one in 2023 following her grandmother’s death and another involving concentrated 7-hydroxymitragynine (7-OH) products after experiencing multiple personal losses in a single night—she returned to her support group and took a leave of absence to regain her recovery.

Concentrated 7-OH products contain much higher levels of the compound than natural leaf kratom, though research shows the human body also converts some mitragynine into 7-OH. The FDA notes that both compounds act on opioid receptors and can contribute to dependence. Tesluck views both forms as interconnected, describing them as “one problem at two strengths.” Mac Haddow, senior fellow on public policy for the American Kratom Association, disputed the equivalence of leaf kratom and concentrated extracts, arguing that bodily conversion does not yield equal exposure, and suggested that Tesluck’s initial capsules may have contained undisclosed ingredients.
Regulatory approaches to kratom remain fragmented across the United States. While states such as Florida prohibit sales to individuals under 21, Washington health officials report that unscheduled kratom products remain largely unregulated without age or testing requirements, and Texas mandates specific labeling with serving sizes. The American Kratom Association supports age restrictions, excise taxes to fund enforcement, and accurate consumer labeling warning of dependence. Meanwhile, the FDA states that no kratom drugs are approved and federal authorities recently seized approximately 73,000 concentrated 7-OH products valued at roughly $1 million from three Missouri firms.

Today, Tesluck serves as executive director of the Virginia-based End Kratom Addiction, meeting with grieving families and coordinating resources for users. She cautions current consumers to monitor warning signs, such as planning daily routines around obtaining the substance, experiencing diminished appetite and hair loss, and feeling like a “zombie shell” of oneself due to irritability and personality changes.